The Efficacy of Venavine Intensive® on the Quality of Life in Females With Chronic Venous Insufficiency
Sponsored by University of Johannesburg
About this trial
Last updated 9 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Ended 10 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Females between the ages thirty to fifty five years;
- experiencing at least three symptoms from Clinical, Etiology, Anatomy and Pathophysiology (CEAP) Classification C1-C4 of CVI, which includes varicose veins, tired or heavy legs, pain in the legs, tingling calves, venous oedema, induration of the legs, brown discolouration in the legs, skin changes such as erythema in the legs; and
- symptoms must be aggravated by walking/standing and symptoms ameliorated by rest and limb elevation.
Exclusion Criteria
- Are pregnant or lactating;
- are on chronic medication for cardiovascular disorder;
- have any chronic diseases that are not sufficiently managed;
- are experiencing CEAP C5-C6 of CVI, including venous ulceration;
- are on Warfarin or blood thinning medication;
- have any liver or kidney pathologies;
- are hypersensitive to any/all herbal extracts;
- are on any treatment (herbal or conventional) for CVI; and/or
- are using compression stockings or Kinesio Taping therapy.